DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Pyridoxamine-5'-Phosphate is an investigational drug.
There have been 6 clinical trials for Pyridoxamine-5'-Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Nephrolithiasis. The leading clinical trial sponsors are Collaborative Study Group (CSG), BioStratum, and NephroGenex, Inc.
There are two US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Pyridoxamine-5'-Phosphate
|Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine||Columbia University||N/A|
|Pyridorin in Diabetic Nephropathy||Collaborative Study Group (CSG)||Phase 3|
|Pyridorin in Diabetic Nephropathy||Medpace, Inc.||Phase 3|
Top disease conditions for Pyridoxamine-5'-Phosphate
Top clinical trial sponsors for Pyridoxamine-5'-Phosphate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pyridoxamine-5'-Phosphate||Start Trial||Methods and compositions for the topical treatment of peripheral neuropathy||Jeffrey S. Brooks, Inc. (St. Louis, MO)||Start Trial|
|Pyridoxamine-5'-Phosphate||Start Trial||Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay||YYZ Pharmatech, Inc. (Toronto, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pyridoxamine-5'-Phosphate||World Intellectual Property Organization (WIPO)||2014186874||2033-05-23||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|